Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP810178.RAbnu2usRowWkEk4gL_LiU8sK1xpHCAkd1HlctCh1BFws130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP810178.RAbnu2usRowWkEk4gL_LiU8sK1xpHCAkd1HlctCh1BFws130_assertion type Assertion NP810178.RAbnu2usRowWkEk4gL_LiU8sK1xpHCAkd1HlctCh1BFws130_head.
- NP810178.RAbnu2usRowWkEk4gL_LiU8sK1xpHCAkd1HlctCh1BFws130_assertion description "[We identified biomarkers that predict for in vitro responsiveness to gefitinib, seven of which have known association with EGFR and head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP810178.RAbnu2usRowWkEk4gL_LiU8sK1xpHCAkd1HlctCh1BFws130_provenance.
- NP810178.RAbnu2usRowWkEk4gL_LiU8sK1xpHCAkd1HlctCh1BFws130_assertion evidence source_evidence_literature NP810178.RAbnu2usRowWkEk4gL_LiU8sK1xpHCAkd1HlctCh1BFws130_provenance.
- NP810178.RAbnu2usRowWkEk4gL_LiU8sK1xpHCAkd1HlctCh1BFws130_assertion SIO_000772 20443891 NP810178.RAbnu2usRowWkEk4gL_LiU8sK1xpHCAkd1HlctCh1BFws130_provenance.
- NP810178.RAbnu2usRowWkEk4gL_LiU8sK1xpHCAkd1HlctCh1BFws130_assertion wasDerivedFrom befree-2016 NP810178.RAbnu2usRowWkEk4gL_LiU8sK1xpHCAkd1HlctCh1BFws130_provenance.
- NP810178.RAbnu2usRowWkEk4gL_LiU8sK1xpHCAkd1HlctCh1BFws130_assertion wasGeneratedBy ECO_0000203 NP810178.RAbnu2usRowWkEk4gL_LiU8sK1xpHCAkd1HlctCh1BFws130_provenance.